Subsequently, AHR was identified as an inhibitor of the canonical Wnt signaling pathway in mouse intestine, being able to suppress intestinal carcinogenesis by degradation of β-catenin [60], with activated AHR expression also downregulating CTNNB1 expression in human colon cancer cell lines [55]. Here, AHR is linked to malignant colon neoplasm.